Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 54 of the 54 references it cites were found in a registry or an index; 18 of the 61 sources its claims cite were checked for support.
Abstract
Mitochondrial complex II is a tumor suppressor comprised of four subunits (SdhA, SdhB, SdhC, and SdhD). Mutations in any of these should disrupt complex II enzymatic activity, yet defects in SdhA produce bioenergetic deficiency while defects in SdhB, SdhC, or SdhD induce tumor formation. The mechanisms underlying these differences are not known. We show that the inhibition of distal subunits of complex II, either pharmacologically or via RNA interference of SdhB, increases normoxic reactive oxygen species (ROS) production, increases hypoxia-inducible factor alpha (HIF-alpha) stabilization in an ROS-dependent manner, and increases growth rates in vitro and in vivo without affecting hypoxia-mediated activation of HIF-alpha. Proximal pharmacologic inhibition or RNA interference of complex II at SdhA, however, does not increase normoxic ROS production or HIF-alpha stabilization and results in decreased growth rates in vitro and in vivo. Furthermore, the enhanced growth rates resulting from SdhB suppression are inhibited by the suppression of HIF-1alpha and/or HIF-2alpha, indicating that the mechanism of SdhB-induced tumor formation relies upon ROS production and subsequent HIF-alpha activation. Therefore, differences in ROS production, HIF proliferation, and cell proliferation contribute to the differences in tumor phenotype in cells lacking SdhB as opposed to those lacking SdhA.
Overview
CoChat Summary
TL;DR
In multiple tumor cell lines and xenografts, suppressing the distal complex II subunit SdhB increased normoxic ROS and HIF-1α/HIF-2α stabilization, enhanced proliferation and tumor growth, whereas suppressing proximal SdhA did not increase ROS/HIF and reduced growth. The SdhB-driven growth phenotype required HIF-1α and/or HIF-2α, supporting an ROS-dependent pseudohypoxic mechanism for SdhB/C/D-linked tumorigenesis.
Key findings
- Pharmacologic inhibition at SdhD with TTFA (200 µM) increased normoxic HIF-1α, HRE-luciferase activity, and ROS (roGFP, DHE, Mito-SOX); SdhA inhibitors 3-NPA (100 µM) and MMA (1 mM) did not, and blocked TTFA-induced HIF-1α stabilization.
- Stable SdhB shRNA in 143B, A549, and Hep3B cells reduced complex II activity and increased normoxic HIF-1α/HIF-2α, VEGF mRNA, HRE-luciferase, and ROS; HIF stabilization was attenuated by ebselen (25 µM), Mito-Q (1 µM), or 3-NPA (100 µM).
- SdhA shRNA reduced complex II activity but did not significantly increase normoxic HIF-1α or ROS and decreased in vitro growth; SdhB shRNA increased in vitro growth and xenograft tumor growth/mass, while SdhA shRNA tumors grew more slowly than wild-type or SdhB shRNA tumors.
- In SdhB shRNA 143B cells, suppressing HIF-1α and/or HIF-2α significantly decreased in vitro growth, tumor growth, and tumor mass compared with dHIF control.
Methods
- Used Hep3B, A549, and 143B cells with stable shRNA against SdhB or SdhA, plus retroviral HIF-1α/HIF-2α shRNA in SdhB shRNA 143B cells; pharmacologic agents included TTFA, 3-NPA, MA, MMA, DMS, ebselen, Mito-Q, and TBAP.
- Measured complex II activity, HIF-1α/HIF-2α/VEGF by immunoblot, HRE-luciferase, ROS by roGFP, DHE, and Mito-SOX, in vitro growth, and nude mouse xenografts (1 × 10⁶ cells; monitored 25–35 days).
- Compared results to wild-type/mock controls; densitometry and P < 0.05 significance were used.
Limitations
- The paper states it cannot rule out that HIF accumulation with SdhD deficiency proceeds by a different mechanism than SdhB suppression, and that the results do not refute ROS production at SdhD via SdhB/C/D mutations.
- The paper notes the H₂O₂-mediated succinate accumulation model is not inconsistent, but required high H₂O₂ (100–500 µM) and it is unclear whether such levels occur in mitochondria.
- Evident from the text: findings rely on shRNA knockdown and pharmacologic inhibitors in three cell lines rather than patient-derived Sdh mutations, and no direct succinate measurements are reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
12 Valid · 0 Not valid · 22 Not checked · 84 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We previously reported that mitochondrial reactive oxygen species (ROS) signals arising from complex III trigger HIF-1 𝛂 stabilization during hypoxia (10, 21, 31).”
What the sources say
- Partly supportedcites [10] 10. Chandel, N. S., E. Maltepe, E. Goldwasser, C. E. Mathieu, M. C. Simon, and P. T. Schumacker. 1998. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95: 11715-11720. sourceExperimental — accuracy not yet measured
Our copy of Chandel et al. (1998) supports the mitochondrial/complex III part: 'Our results show that ROS generation at complex III is required for the induction of HIF-1 DNA binding activity during hypoxia' (Results and Discussion), and 'mitochondrial complex III acts as a principal site of ROS generation during hypoxia.' However, the endpoint the paper demonstrates is HIF-1 DNA-binding activity (gel shift) and downstream EPO/VEFG/glycolytic mRNA, not HIF-1α protein stabilization — the paper attributes stabilization to others ('hypoxic stabilization of the HIF-1 complex is related to the O2 concentration (31)', and Caro and Salceda (28) for lactacystin-induced stabilization). The claim's causal 'trigger' also outruns the paper's explicit hedge: 'Our model proposes only that ROS are required for the hypoxic activation of HIF-1, but it is not yet clear whether ROS are sufficient,' with ROS generators (antimycin, menadione) failing to elicit HIF-1 stabilization during normoxia. (LLM, conf=0.78)
- Not checked yetcites [21] 21. Guzy, R. D., B. Hoyos, E. Robin, H. Chen, L. Liu, K. D. Mansfield, M. C. Simon, U. Hammerling, and P. T. Schumacker. 2005. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1: 401-408. source
- Not checked yetcites [31] 31. Mansfield, K. D., R. D. Guzy, Y. Pan, R. M. Young, T. P. Cash, P. T. Schumacker, and M. C. Simon. 2005. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF𝛂 activation. Cell Metab. 1: 393-399. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“An impairment in the normal removal of electrons from the flavin group in SdhA could promote superoxide generation through the autoxidation of the reduced flavin group by O 2 in the matrix (34, 38, 46, 51).”
What the sources say
- Partly supportedcites [34] 34. Messner, K. R., and J. A. Imlay. 2002. Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase. J. Biol. Chem. 277: 42563-42571. sourceExperimental — accuracy not yet measured
Our copy supports the mechanistic core: the flavin is the autoxidizing site in Sdh/Frd ('Flavin as the Site of Autoxidation'), Sdh 'makes only O2.-, and no H2O2, upon flavin autoxidation' (Succinate Dehydrogenase Makes Only Superoxide..., Fig. 9), and 'the relative preference of electrons to sit on the flavin is a major determinant of their tendency to autoxidize,' with Sdh's cofactor potentials 'arranged to withdraw electrons away from the flavin,' which 'may largely explain its comparatively low rate of autoxidation' — i.e. electrons retained on the flavin raise superoxide formation. Not supported by this paper: the specific counterfactual about an 'impairment in the normal removal of electrons from the flavin group in SdhA' (our copy names Sdh/FrdA mutants such as FrdA H44C and FrdB C62S, never an SdhA lesion), and the mitochondrial 'matrix' location — the work was done in E. coli inverted membrane vesicles with no reference to a matrix. (LLM, conf=0.75)
- Partly supportedcites [38] 38. Rustin, P., and A. Roetig. 2002. Inborn errors of complex II-unusual human mitochondrial diseases. Biochim. Biophys. Acta Bio-Energetics 1553: 117122. sourceExperimental — accuracy not yet measured
The Fig. 2 legend embedded in Section 3 ('Mutations in SDH B encoding the Ip subunit') does support the core idea for the SDH (Fp/Ip) subunits, including SdhA: 'some particular mutation could still favor an over-reduction of a given SDH component (e.g. flavin), resulting in superoxide production', and Section 5 adds that CII (SDH?) 'is a privileged location for superoxide production'. However, our copy nowhere states the specific mechanism the claim attributes — autoxidation of the reduced flavin by O2 — nor localises it to the matrix side (Fig. 1's legend only describes semi-quinone feeding electrons to the UQ pool). Searches for 'autoxidation', 'reduced flavin + O2' and 'matrix' returned no supporting passage, so the mechanistic detail likely rests on the sentence's other citations (34, 38, 46, 51) rather than this paper. (LLM, conf=0.72)
- Partly supportedcites [46] 46. Senoo-Matsuda, N., K. Yasuda, M. Tsuda, T. Ohkubo, S. Yoshimura, H. Nakazawa, P. S. Hartman, and N. Ishii. 2001. A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J. Biol. Chem. 276: 41553-41558. sourceExperimental — accuracy not yet measured
Our copy supports the general premise — that impaired electron flow through complex II can raise superoxide production — with the DISCUSSION passage speculating that 'the complex II defect could affect electron flow such that there is a probable increase of electrons leaking directly from complex II to molecular oxygen,' and the Abstract identifying SDHA/Fp as the flavoprotein subunit. However, the paper never attributes superoxide generation to autoxidation of the reduced flavin group of SdhA by matrix O2; its specific proposed mechanism is premature release of semiquinone at the ubiquinone-binding site of Cyt-1/ceSDHC (residue 71, the mev-1 mutation), DISCUSSION. The flavin-autoxidation element of the claim is therefore absent from this source. (LLM, conf=0.72)
- Not checked yetcites [51] 51. Yankovskaya, V., R. Horsefield, S. Toernroth, C. Luna-Chavez, H. Miyoshi, C. Leger, B. Byrne, G. Cecchini, and S. Iwata. 2003. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 299: 700-704. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Complex II oxidizes succinate to fumarate and transfers the electrons to ubiquinone through a sequence of steps involving a flavin moiety in SdhA, a set of iron-sulfur clusters in SdhB, a heme group in SdhC, and the ubiquinone binding site in SdhC and SdhD (Fig. 1) (1, 9).”
What the sources say
- Partly supportedcites [1] 1. Ackrell, B. A. C. 2000. Progress in understanding structure-function relationships in respiratory chain complex II. FEBS Lett. 466: 1-5. sourceExperimental — accuracy not yet measured
The Introduction says complex II oxidizes succinate to fumarate and transfers electrons to ubiquinone; it also places FAD in the flavoprotein, three iron–sulfur clusters in the iron–sulfur subunit, and quinone-binding sites in the membrane anchors. Sections 3 and 4 describe electron transfer from FAD through the clusters to bound quinone, but do not place heme in that transfer sequence. Section 4 describes heme as coordinated by anchor helices and emphasizes its role in assembly, so the claim that electrons pass through a heme in SdhC is not supported. (LLM, conf=0.88)
- Not checked yetcites [9] 9. Cecchini, G. 2003. Function and structure of complex II of the respiratory chain. Annu. Rev. Biochem. 72: 77-109. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, mutations in subunit SdhB, SdhC, or SdhD are linked to tumorigenesis in the form of autosome-dominant familial paragangliomas and pheochromocytomas (1, 3, 16, 19, 33).”
What the sources say
- Could not verifycites [1] 1. Ackrell, B. A. C. 2000. Progress in understanding structure-function relationships in respiratory chain complex II. FEBS Lett. 466: 1-5. sourceExperimental — accuracy not yet measured
The Introduction discusses mutated respiratory-chain complex II in nematodes, and §2 (Flavoprotein subunit) describes a human mutation causing complex II deficiency. Neither passage addresses SDHB, SDHC, or SDHD mutations in familial paragangliomas or pheochromocytomas; searches for those tumors and for familial SDH mutations found no relevant passage. Page numbers were not available in our copy. (LLM, conf=0.75)
- Not checked yetcites [3] 3. Baysal, B. E., R. E. Ferrell, J. E. Willett-Brozick, E. C. Lawrence, D. Myssiorek, A. Bosch, A. van der Mey, P. E. Taschner, W. S. Rubinstein, E. N. Myers, C. W. Richard III, C. J. Cornelisse, P. Devilee, and B. Devlin. 2000. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848-851. source
- Not checked yetcites [16] 16. Douwes Dekker, P. B. D., P. C. W. Hogendoorn, N. Kuipers-Dijkshoorn, F. A. Prins, S. G. Van Duinen, P. E. M. Taschner, A. G. L. Van der Mey, and C. J. Cornelisse. 2003. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J. Pathol. 201: 480-486. source
- Supportedcites [19] 19. Gimenez-Roqueplo, A. P., J. Favier, P. Rustin, J. J. Mourad, P. F. Plouin, P. Corvol, A. Roetig, and X. Jeunemaitre. 2001. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am. J. Hum. Genet. 69: 1186-1197. source
The Discussion identifies SDHD, SDHC, and SDHB mutations as responsible for familial paraganglioma and describes its inheritance as usually autosomal dominant. The Introduction reports familial pheochromocytoma associated with SDHD and SDHB mutations; the paper's own family had an SDHD mutation and both tumor types. Page numbers were not provided in our copy. (LLM, conf=0.91)
- Partly supportedcites [33] 33. McWhinney, S. R., R. T. Pilarski, S. R. Forrester, M. C. Schneider, M. M. Sarquis, E. P. Dias, and C. Eng. 2004. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J. Clin. Endocrinol. Metab. 89: 5694-5699. sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) says germline mutations in SDHB, SDHC, and SDHD cause hereditary pheochromocytoma/paraganglioma syndrome, supporting the link to familial tumors. Our copy explicitly calls SDHC-associated paraganglioma autosomal dominant in a reference title, but does not establish that inheritance pattern for all three genes; the Discussion (page unavailable) also notes maternal imprinting in SDHD-associated disease. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Other studies with diverse model systems also indicate that mutations in complex II can cause increases in ROS production (24, 25, 46, 51, 54).”
What the sources say
- Not checked yetcites [24] 24. Ishiguro, H., K. Yasuda, N. Ishii, K. Ihara, T. Ohkubo, M. Hiyoshi, K. Ono, N. Senoo-Matsuda, O. Shinohara, F. Yosshii, M. Murakami, P. S. Hartman, and M. Tsuda. 2001. Enhancement of oxidative damage to cultured cells and Caenorhabditis elegans by mitochondrial electron transport inhibitors. IUBMB Life 51: 263-268. source
- Not checked yetcites [25] 25. Ishii, N., M. Fujii, P. S. Hartman, M. Tsuda, K. Yasuda, N. Senoo-Matsuda, S. Yanase, D. Ayusawa, and K. Suzuki. 1998. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 394: 694-697. source
- Supportedcites [46] 46. Senoo-Matsuda, N., K. Yasuda, M. Tsuda, T. Ohkubo, S. Yoshimura, H. Nakazawa, P. S. Hartman, and N. Ishii. 2001. A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J. Biol. Chem. 276: 41553-41558. source
Our copy directly demonstrates the attributed point: the Results section 'Production of Superoxide Anion from Mitochondria Is Elevated in mev-1 Mutants' reports ~2-fold higher superoxide production in mitochondria and SMP from mev-1 animals (which carry a missense mutation in Cyt-1/ceSDHC, the complex II cytochrome b large subunit) versus wild type, and the Discussion summary states mev-1 animals manifest 'superoxide anion overproduction from mitochondrial complex II itself... by the mutation in Cyt-1/ceSDHC subunit.' The hedged 'can cause' in the citing sentence matches the source's claim, and the paper's caveat that the effect is allele-specific (residue 71 missense; more severe mutations may not elevate superoxide) does not contradict a possibility-level statement. The one organism studied (C. elegans) is not overstated by the citing sentence, which pools this with other model systems. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
65 more claims · 2 with their cited sources checked
Create a free account to see all 118 claims and to verify the 43 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 40
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This requires both succinate oxidation by the enzyme succinate dehydrogenase (SDH) and an increase in mitochondrial membrane potential.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has also been reported that defects in SDH B increase ROS production and that ROS enhance the stabilization of HIFα produced by succinate accumulation (Guzy et al., 2007), although the importance of ROS in this setting has been disputed (Lee et al., 2005; Selak et al., 2006).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Guzy et al., 2007
The cited source says what the claim attributes to it.
In the citing paper
“Accumulation of reactive oxygen species, an independent trigger for HIF stabilization, may contribute to this process in some cases of defective SDH or FH (Guzy et al., 2008; Sudarshan et al., 2009).”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Guzy et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ MATERIALS AND METHODS
“For dihydroethidium (DHE) and Mito-SOX experiments, cells were treated with the appropriate conditions for 5 to 6 h before the addition of DHE (10 𝛍 M) or Mito-SOX (1 𝛍 M) to the culture medium. Cells were incubated for an additional 1.5 h”
§ RESULTS
“After treatment for 5 h, DHE (1 𝛍 M) was added for an additional hour.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ RESULTS
“either polyclonal (SdhA clone 3) or monoclonal (SdhA clones 3C and 3L)”
§ RESULTS
“a monoclonal SdhA shRNA line (SdhA polyclonal line 3C)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ MATERIALS AND METHODS
“Cells were incubated for an additional 1.5 h before being trypsinized and resuspended.”
§ RESULTS
“(H) Cells were treated with the indicated compounds for 5 h, after which Mito-SOX (1 𝛍 M) was added for an additional hour.”
Citations
Cites
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 7×
“In a previous study, the suppression of SdhD expression led to an increase in HIF-1 stabilization, a response that was attributed to the inhibition of PHD by succinate that accumulated as a consequence of the impairment in complex II activity ( 43 ).”
BackgroundMethodInfluentialOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068 · cited 1×
“A similar model of substrate-mediated PHD inhibition has been described (23, 37, 42) in which the loss of fumarate hydratase activity leads to the accumulation of fumarate, which also can inhibit PHD competitively.”
BackgroundChandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Self-citationMitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 2×
“Previous studies have implicated complex III in the cellular O2-sensing pathway involved in the regulation of HIF- stability during hypoxia (10, 21).”
BackgroundSelf-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“However, mutations in subunit SdhB, SdhC, or SdhD are linked to tumorigenesis in the form of autosome-dominant familial paragangliomas and pheochromocytomas (1, 3, 16, 19, 33).”
BackgroundMitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545
Self-citationUbisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria
Turrens, J. F., Alexandre, A., & Lehninger, A. L. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90293-0 · Cited by 1,214 · cited 1×
“Those interventions would be expected to increase cytosolic superoxide levels, because AA generates superoxide at the outer surface of the inner mitochondrial membrane (50) while p53 induces the expression of a variety of nonmitochondrial oxidase systems (53).”
BackgroundHanson, G. T., Aggeler, R., Oglesbee, D., Cannon, M., Capaldi, R. A., Tsien, R. Y., & Remington, S. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312846200 · Cited by 988 · cited 1×
“Using a novel, engineered, ratiometric fluorescent protein redox sensor (roGFP) (15, 22) expressed in cells by using a recombinant adenovirus, we find that the acute administration of TTFA significantly increases the rate of protein thiol oxidation compared to that induced by 3-NPA, MMA (Fig.”
BackgroundIsaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958 · cited 1×
“A similar model of substrate-mediated PHD inhibition has been described ( 23 , 37, 42) in which the loss of fumarate hydratase activity leads to the accumulation of fumarate, which also can inhibit PHD competitively.”
BackgroundArchitecture of succinate dehydrogenase and reactive oxygen species generation
Yankovskaya, V., Horsefield, R., Törnroth, S., Luna-Chavez, C., Miyoshi, H., Léger, C., Byrne, B., Cecchini, G., & Iwata, S. (2003) · Science · doi:10.1126/science.1079605 · Cited by 927 · cited 5×
“... II oxidizes succinate to fumarate and transfers the electrons to ubiquinone through a sequence of steps involving a flavin moiety in SdhA, a set of iron-sulfur clusters in SdhB, a heme group in SdhC, and the ubiquinone binding site in SdhC and SdhD (Fig. 1) (1, 9). When complex II is disrupted at SdhB, SdhC, or Sd…”
BackgroundInfluential
Cited by
Items 101–200 of 426
Physiological Phenotype and Vulnerability in Parkinson's Disease
Surmeier, D. J., Guzman, J. N., Sanchez, J., & Schumacker, P. T. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009290 · Cited by 117
“This condition enhances the nonspecific generation of superoxide, which appears to enhance the tendency to form tumors (Guzy et al. 2008).”
BackgroundSelf-citationIron: An Essential Element of Cancer Metabolism
Hsu, M. Y., Mina, E., Roetto, A., & Porporato, P. E. (2020) · Cells · doi:10.3390/cells9122591 · Cited by 127
“Furthermore, SDHB-silencing was sufficient to induce ROS generation and metabolic switch, which increased cancer cell proliferation and tumor growth in vivo [95,96].”
BackgroundDisease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB
Maio, N., Ghezzi, D., Verrigni, D., Rizza, T., Bertini, E., Martinelli, D., Zeviani, M., Singh, A., Carrozzo, R., & Rouault, T. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.005 · Cited by 114
“S6C), as flavo-SDHA converts succinate to fumarate (Guzy et al., 2008; Lemarie et al., 2011; Senoo-Matsuda et al., 2001; Yankovskaya et al., 2003) (Figure 7E).”
SDHAF4 Promotes Mitochondrial Succinate Dehydrogenase Activity and Prevents Neurodegeneration
Vranken, J. G. V., Bricker, D. K., Dephoure, N., Gygi, S. P., Cox, J. E., Thummel, C. S., & Rutter, J. P. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.012 · Cited by 119
“This oxidation of succinate leads to the reduction of FAD, which is then auto-oxidized bymolecular oxygen to yield superoxide (Messner and Imlay, 2002; Guzy et al., 2008).”
BackgroundPheochromocytomas: The (pseudo)-hypoxia hypothesis
Favier, J., & Gimenez‐Roqueplo, A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.004 · Cited by 124
Fliedner, S. M. J., Lehnert, H., & Pacák, K. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.10.017 · Cited by 116
O'Flaherty, L., Adam, J., Heather, L. C., Zhdanov, A. V., Chung, Y.-L., Miranda, M. X., Croft, J., Olpin, S., Clarke, K., Pugh, C. W., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq305 · Cited by 109
Succinate in the cancer–immune cycle
Jiang, S., & Yan, W. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.019 · Cited by 117
Mitochondrial complex II, a novel target for anti-cancer agents
Kluckova, K., Bezawork-Geleta, A., Rohlena, J., Dong, L., & Neuzil, J. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.10.015 · Cited by 104
“However, various groups using various models have reported either increased or normal levels of ROS in CII deficient cells, and this issue remains to be resolved [69, 70, 72, 73].”
Illsley, N. P., Caniggia, I., & Zamudio, S. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082798ni · Cited by 107
“In addition, the inhibition of complex II increases levels of succinate (Guzy et al., 2008; King et al., 2006 ), which acts as a competitive inhibitor of the enzyme regulating HIF-1α degradations, the prolyl hydroxlase domain-containing protein (PHD)(Lu et al., 2005; Stolze et al., 2006).”
BackgroundTseng, P., Wu, W.-H., Hu, T., Chen, C., Cheng, H.-C., Li, C., Tsai, W., Tsai, H.-J., Hsieh, M.-C., Chuang, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21361-6 · Cited by 129
Case, A. J., McGill, J. L., Tygrett, L. T., Shirasawa, T., Spitz, D. R., Waldschmidt, T. J., Legge, K. L., & Domann, F. E. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.025 · Cited by 107
“Succinate dehydrogenase activity assay was adapted from the previously described experiment [49].”
MethodEndothelial Cell Energy Metabolism, Proliferation, and Apoptosis in Pulmonary Hypertension
Xu, W., & ERZURUM, S. C. (2010) · Comprehensive physiology · doi:10.1002/cphy.c090005 · Cited by 129
“…pathogenic role of HIF-1 α in PH is validated by genetic deletion of HIF-1 α (156) or HIF-2 α (23) heterozygous cellular respiration through mutation of complex II increases HIF-1 α stabilization and activates numerous intracellular signaling and transcriptional pathways (27,28,51,117,152 ).”
Metabolic dysregulation in monogenic disorders and cancer — finding method in madness
Erez, A., & DeBerardinis, R. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3949 · Cited by 105
Bajpai, R., Sharma, A., Achreja, A., Edgar, C. L., Wei, C., Siddiqa, A., Gupta, V. A., Matulis, S. M., McBrayer, S. K., Mittal, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15051-z · Cited by 108
“Complex II is linked to the generation of ROS, accumulation of succinate and the induction of HIF1-α 54 that can lead to induction of ATF4 55 .”
BackgroundHielscher, A., & Gerecht, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.09.015 · Cited by 103
“For instance, RNA interference of the tumor suppressor succinate-ubiquinone oxidorectase (SdhB), a component of mitochondrial complex II, resulted in ROS formation and ROS-dependent HIF-1α stabilization in hepatoma, lung carcinoma and osteosarcoma cell lines under normoxic conditions [47].”
BackgroundMitochondrial c-Src regulates cell survival through phosphorylation of respiratory chain components
Ogura, M., Yamaki, J., Homma, M. K., & Homma, Y. (2012) · Biochemical Journal · doi:10.1042/bj20120509 · Cited by 116
Lemarie, A., Huc, L., Pazarentzos, E., Mahul-Mellier, A.-L., & Grimm, S. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.93 · Cited by 98
“on the cause of complex II inhibition, notably at the SDHC/D CoQ-binding site(32) or between the SDHA-embedded FAD group and a downstream obstruction.(33) Nevertheless, the”
Mitochondrial fumarate reductase as a target of chemotherapy: From parasites to cancer cells
Sakai, C., Tomitsuka, E., Esumi, H., Harada, S., & Kita, K. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.12.013 · Cited by 96
Lorendeau, D., Rinaldi, G., Boon, R., Spincemaille, P., Metzger, K., Jäger, C., Christen, S., Dong, X., Kuenen, S., Voordeckers, K., et al. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.11.005 · Cited by 104
Modulating Mitochondrial Intracellular Location as a Redox Signal
Murphy, M. P. (2012) · Science Signaling · doi:10.1126/scisignal.2003386 · Cited by 91
Rare insights into cancer biology
Adam, J., Yang, M., Soga, T., & Pollard, P. J. (2013) · Oncogene · doi:10.1038/onc.2013.222 · Cited by 93
SDHi fungicides: An example of mitotoxic pesticides targeting the succinate dehydrogenase complex
Tête, A., Debizet, K., Imler, J., Tomkiewicz, C., Blanc, É., Barouki, R., Coumoul, X., & Bortoli, S. (2023) · Environment International · doi:10.1016/j.envint.2023.108219 · Cited by 106
Clinical and molecular progress in hereditary paraganglioma: Figure 1
Baysal, B. E. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058560 · Cited by 86
Respiratory chain complex II as general sensor for apoptosis
Grimm, S. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.09.009 · Cited by 82
Lung Cell Hypoxia: Role of Mitochondrial Reactive Oxygen Species Signaling in Triggering Responses
Schumacker, P. T. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201103-032mw · Cited by 95
Self-citationPhysiological consequences of complex II inhibition for aging, disease, and the mKATP channel
Wojtovich, A. P., Smith, C. O., Haynes, C. M., Nehrke, K. W., & Brookes, P. S. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.12.007 · Cited by 83
Huang, S., Braun, H., Gawryluk, R. M. R., & Millar, A. H. (2019) · The Plant Journal · doi:10.1111/tpj.14227 · Cited by 92
Hypoxia-Adaptation Involves Mitochondrial Metabolic Depression and Decreased ROS Leakage
Ali, S. S., Hsiao, M., Zhao, H. W., Dugan, L. L., Haddad, G. G., & Zhou, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036801 · Cited by 85
“It has been shown that complex III mediated ROS signals trigger HIF-1a stabilization in response to acute hypoxia [38,39,40,41].”
BackgroundMitochondrial Metabolism in Carcinogenesis and Cancer Therapy
Moindjie, H., Rodrigues, S., & Nahmias, C. (2021) · Cancers · doi:10.3390/cancers13133311 · Cited by 93
“Thus, mutations in mitochondrial enzymes induce a tumorigenic hypoxia-like state mediated by HIF-1 stabilization and accumulation of ROS that promotes tumor growth [40].”
BackgroundHypoxia-Inducible Factor 1 and Mitochondria: An Intimate Connection
Huang, X., Zhao, L., & Peng, R. (2022) · Biomolecules · doi:10.3390/biom13010050 · Cited by 96
“[70] demonstrated that HIF-α stabilization was increased in an ROS-dependent manner when the distal subunits of complex II were inhibited.”
BackgroundThe twisted survivin connection to angiogenesis
Sanhueza, C. T., Wehinger, S., Bennett, J., Valenzuela, M., Owen, G. I., & Quest, A. F. G. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0467-1 · Cited by 93
“Moreover, reduced activity of mitochondrial complex II (succinate-ubiquinone oxidoreductase, Sdh) due to diminished activity of the B subunit (ShdB) in such cells, favors tumor cell growth in a HIF1α-dependent manner [55].”
BackgroundDysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
Marbaniang, C., & Kma, L. (2018) · PubMed · doi:10.22034/apjcp.2018.19.9.2377 · Cited by 79
“ROS generated from complexes II and III in the mitochondria also mediates HIF-1α stabilization (Guzy et al., 2005; Guzy et al., 2008; Klimova and Chandel, 2008).”
BackgroundKoenig, A., & Buskiewicz, I. A. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0073 · Cited by 81
“Sta-bilization of HIF-1 a can also occur independently from succinate’s interaction with PHD, as HIF-1 a levels were shown to be increased by direct action of mtROS (66, 143).”
Hypoxia-induced changes in pulmonary and systemic vascular resistance: Where is the O2 sensor?
Waypa, G. B., & Schumacker, P. T. (2010) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2010.08.007 · Cited by 79
Self-citationLaurenti, G., & Tennant, D. A. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160099 · Cited by 91
“Mutations in SDHC and SDHB but not SDHA subunits have been shown to directly lead to increased ROS production and in the case of SDHC, elevated rates of DNA mutation [24, 25].”
BackgroundRedox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism
Olsen, R. K. J., Cornelius, N., & Gregersen, N. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9861-5 · Cited by 93
Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma
Feichtinger, R. G., Zimmermann, F., Mayr, J. A., Neureiter, D., Hauser‐Kronberger, C., Schilling, F. H., Jones, N., Sperl, W., & Kofler, B. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-149 · Cited by 82
“Suppressed SDHB protein can be found in pheochromocytomas with loss of VHL [19,36].”
BackgroundTargeting mTOR Signaling Can Prevent the Progression of FSGS
Zschiedrich, S., Bork, T., Liang, W., Wanner, N., Eulenbruch, K., Munder, S., Hartleben, B., Kretz, O., Gerber, S., Simons, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016050519 · Cited by 76
Lendvai, N., Pawlosky, R., Bullova, P., Eisenhofer, G., Patocs, A., Veech, R. L., & Pacak, K. (2014) · Endocrinology · doi:10.1210/en.2013-1549 · Cited by 76
Metabolic determinants of tumour initiation
Brunner, J. S., & Finley, L. W. S. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00773-5 · Cited by 87
Inter‐connection between mitochondria and HIFs
Tormos, K. V., & Chandel, N. S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01031.x · Cited by 74
“Indeed, RNAi against SDHA protein does not increase ROS, HIF activation or tumorigenicity [46].”
BackgroundInfluentialSelf-citationOH, the Places You’ll Go! Hydroxylation, Gene Expression, and Cancer
Ploumakis, A., & Coleman, M. L. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.026 · Cited by 83
“For example, inhibition of HIFa expression in tumor cells with stable SDHB knockdown reduces their growth as xenografts (Guzy et al., 2008).”
BackgroundPang, Y. K., Lu, Y., Caisová, V., Liu, Y., Bullova, P., Huynh, T., Zhou, Y., Yu, D., Fryšák, Z., Hartmann, I., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3406 · Cited by 82
The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
Scagliola, A., Mainini, F., & Cardaci, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7974 · Cited by 84
“Guzy et al. proposed a tumor-supportive role for reactive oxygen species (ROS) produced as a consequence of inhibition or hy-poexpression of SDHB subunit in cancer cells (38).”
Banerjee, S., Ghosh, S., Mandal, A., Ghosh, N., & Sil, P. C. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02801-7 · Cited by 76
“ROS production in macrophages during inflammatory response also stabilizes HIF-1α through oxidation of cysteine residues on PHD. Excessive ROS decarboxylate α-ketoglutarate and also oxidize iron which is required for stabilization of PHD (Corcoran and O’Neill 2016; Guzy et al.”
BackgroundInfluentialPhaeochromocytoma: a catecholamine and oxidative stress disorder
Pacák, K. (2011) · Endocrine Regulations · doi:10.4149/endo_2011_02_65 · Cited by 79
Overcoming the Warburg Effect: Is it the key to survival in sepsis?
Bar‐Or, D., Carrick, M. M., Tanner, A. H., Lieser, M. J., Rael, L. T., & Brody, E. N. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.09.012 · Cited by 79
“The plausibility of this pathway being partly responsible for the increased succinate seen in severe inflammation is supported by the normoxic stabilization of HIF-1α and ROS production seen when succinate is increased due tomutations in the succinate dehydrogenase gene (complex II in the electron transport chain) [51…”
BackgroundMeng, X., Dunsmore, G., Koleva, P. T., Elloumi, Y., Wu, R., Sutton, R. T., Ambrosio, L., Hotte, N., Nguyen, V. V., Madsen, K. L., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy186 · Cited by 79
Mutation of SDHB is a Cause of Hypoxia-Related High-Altitude Paraganglioma
Cerecer-Gil, N. Y., Figuera, L. E., Llamas, F. J., Lara, M., Escamilla, J. G., Ramos, R., Estrada, G., Hussain, A. K., Gaal, J., Korpershoek, E., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0637 · Cited by 71
Goffrini, P., Ercolino, T., Panizza, E., Giache, V., Cavone, L., Chiarugi, A., Dima, V., Ferrero, I., & Mannelli, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp102 · Cited by 69
Hoerner, C. R., Chen, V. J., & Fan, A. C. (2019) · Kidney Cancer · doi:10.3233/kca-180043 · Cited by 68
Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate
Goncalves, J., Moog, S., Morin, A., Gentric, G., Müller, S., Morrell, A. P., Kľučková, K., Stewart, T. J., Andoniadou, C. L., Lussey‐Lepoutre, C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2936 · Cited by 81
“In contrast, Guzy and colleagues proposed that the mechanism explaining PPGL tumorigenesis following SDH inhibition was an increase in ROS production, acting as messengers able to activate pseudohypoxic responses and probably resulting in oxidative damage to DNA, genomic instability, and tumorigenesis (53).”
BackgroundSDH5 mutations and familial paraganglioma: somewhere Warburg is smiling
Kaelin, W. G. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.013 · Cited by 67
“Moreover, loss of SDH or FH activity has been reported to increase mitochondrial ROS production, which also inhibits dioxygenase function (Guzy et al., 2008; Sudarshan et al., 2009).”
BackgroundHypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
Ortmann, B. M. (2024) · BMJ Oncology · doi:10.1136/bmjonc-2023-000154 · Cited by 67
Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
Kľučková, K., & Tennant, D. A. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2801-6 · Cited by 70
“However, the experimental evidence for increased ROS in various models of SDH dysfunction is not consistent, with evidence suggesting that they are increased (Guzy et al. 2008; Ishii et al. 2005; Saito et al. 2016) or normal (Cervera et al. 2008; Selak et al. 2005).”
BackgroundA role for human mitochondrial complex II in the production of reactive oxygen species in human skin
Anderson, A., Bowman, A., Boulton, S. J., Manning, P., & Birch-Machin, M. A. (2014) · Redox Biology · doi:10.1016/j.redox.2014.08.005 · Cited by 65
“In a novel approach we have used an array of established specific metabolic inhibitors and DHR123 fluorescence to study the relative roles of the mitochondrial RC complexes in cellular ROS production in 2 types of human skin cells.”
MethodHypoxic pulmonary vasoconstriction: mechanisms of oxygen-sensing
Evans, A. M., Hardie, D. G., Peers, C., & Mahmoud, A. D. (2010) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3283421201 · Cited by 80
Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
Morfoisse, F., Renaud-Gabardos, E., Hantelys, F., Prats, A., & Garmy-Susini, B. H. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29907 · Cited by 74
Pheochromocytoma: The First Metabolic Endocrine Cancer
Jochmanová, I., & Pacák, K. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0606 · Cited by 70
“SDHBmutations in particular were reported to cause a significant increase in ROS production and mitochondrial DNA mutability (70, 71), although pseudohypoxia can be observed in SDH-suppressed cells, even in the absence of oxidative stress (61, 72).”
BackgroundWang, H., Chen, Y., & Wu, G. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.09.009 · Cited by 65
“SDHB mutation has been recently reported to cause respiratory chain dysfunction and hypoxia inducible factors (HIFs) stabilization with a subsequent state of pseudohypoxia [16].”
BackgroundMitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis
Fetisova, E. K., Chernyak, B. V., Korshunova, G. A., Muntyan, M. S., & Skulachev, V. P. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170316114452 · Cited by 65
Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
Pollard, P. J., Yang, M., Su, H., Soga, T., & Kranc, K. R. (2014) · Hypoxia · doi:10.2147/hp.s47968 · Cited by 87
“However, it has also been argued that, because PHDs have a tight binding affinity for 2OG, the activation of HIF in the SDHor FH-deficient settings is likely to be due to inactivation of PHDs by oxidative stress, which is generated as a result of mitochondrial dysfunction.(101,102) Gain of function mutations in IDH1 a…”
BackgroundInsights into the Pathogenesis and Treatment of Cancer from Inborn Errors of Metabolism
Erez, A., Shchelochkov, O. A., Plon, S. E., Scaglia, F., & Lee, B. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.005 · Cited by 67
“Cancer-predisposing mutations in genes encoding the SDHA, SDHB, SDHC, and SDHD subunits of mitochondrial complex II have all been reported.(110) Mutations in SDHB are more likely to result in metastatic paragangliomas.”
BackgroundHigh Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates With Lower Survival
Stanke, K. M., Wilson, C., & Kidambi, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.752404 · Cited by 70
Chang, S., Jiang, X., Zhao, C., Lee, C., & Ferriero, D. M. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.005 · Cited by 66
“There is emerging evidence that not only hypoxia (through inhibition of prolyl hydroxylase-dependent degradation of HIF-1α), but also H2O2 is a critical factor in the activation of HIF-1 and regulation of its activity [3,4,10,12,19,28,35].”
BackgroundThe Involvement of Metallothioneins in Mitochondrial Function and Disease
Lindeque, J. Z., Levanets, O., Louw, R., & van der Westhuizen, F. H. (2010) · Current Protein and Peptide Science · doi:10.2174/138920310791233378 · Cited by 73
“…is quickly dismutated by superoxide dismutases to hydrogen peroxide (H2O2) (Boveris & Cadenas, and III to produce superoxide (Boveris & Chance, 1973; Liu et al., 2002; Turrens & Boveris, 1980) as well as from α-ketoglutarate dehydrogenase (Starkov et al., 2004) or complex II (Guzy et al., 2008).”
BackgroundRapid High-pH Reverse Phase StageTip for Sensitive Small-Scale Membrane Proteomic Profiling
Dimayacyac-Esleta, B. R. T., Tsai, C., Kitata, R. B., Lin, P.-Y., Choong, W.-K., Lin, T., Wang, Y.-T., Weng, S., Yang, P., Arco, S. D., et al. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03639 · Cited by 64
Baysal, B. E., & Maher, E. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0226 · Cited by 64
“In addition to stabilizing HIF1a (Guzy et al. 2008), ROS generated by SDHC mutations has also been implicated in mutating nuclear DNA and therefore contributing to tumorigenesis (Ishii et al.”
BackgroundCyr, A. R., Hitchler, M. J., & Domann, F. E. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4850 · Cited by 67
“Multiple groups have shown that PHD enzymes are perturbed by increased succinate and oxidative stress secondary to SDH activity loss, leading to a pseudo-hypoxic state in which HIF is stabilized in the absence of true hypoxia (1, 14, 40).”
BackgroundMitochondrial Redox Hubs as Promising Targets for Anticancer Therapy
Ippolito, L., Giannoni, E., Chiarugi, P., & Parri, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00256 · Cited by 67
NRF2 in human neoplasm: Cancer biology and potential therapeutic target
Liu, Y., Lang, F., & Yang, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107664 · Cited by 61
Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
Morfoisse, F., Renaud-Gabardos, E., Hantelys, F., Prats, A., & Garmy-Susini, B. H. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1024821 · Cited by 73
Assembly of mitochondrial succinate dehydrogenase in human health and disease
Cao, K. J., Xu, J., Cao, W., Wang, X., Lv, W., Zeng, M., Zou, X., Liu, J., & Feng, Z. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.023 · Cited by 68
Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects
Pepe, S., Korbonits, M., & Iacovazzo, D. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0446 · Cited by 65
The genetic basis of isolated mitochondrial complex II deficiency
Fullerton, M., McFarland, R., Taylor, R. W., & Alston, C. L. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.09.009 · Cited by 57
Redox Signaling from Mitochondria: Signal Propagation and Its Targets
Ježek, P., Holendová, B., & Plecitá‐Hlavatá, L. (2020) · Biomolecules · doi:10.3390/biom10010093 · Cited by 62
“A knockdown of Complex I subunit NDUFA13 (GRIM‐19) leads to increased superoxide formation which subsequently causes HIF1α stabilization plus accelerated autophagy [179,180].”
BackgroundWang, X., Zhang, X., Cao, K. J., Zeng, M., Fu, X., Zheng, A., Zhang, F., Gao, F., Zou, X., Li, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31548-1 · Cited by 62
Succinate Dehydrogenase and Ribonucleic Acid Networks in Cancer and Other Diseases
Moreno, C., Santos, R. M., Burns, R., & Zhang, W. C. (2020) · Cancers · doi:10.3390/cancers12113237 · Cited by 62
“All of these specific genetic mutations are known to increase ROS production [22], which leads to DNA damage and tumorigenesis [33].”
BackgroundGobelli, D., Serrano‐Lorenzo, P., Esteban-Amo, M. J., Serna, J., Pérez-García, M. T., Orduña, A., Jourdain, A. A., Martín, M. A., de la Fuente, M. Á., & Simarro, M. (2023) · iScience · doi:10.1016/j.isci.2023.107473 · Cited by 63
“However, the inhibition of SDHA, again either pharmacologically or via RNA interference, fails to increase ROS production or induce HIF-1a stabilization and results in decreased growth rates in vitro and in vivo.(12) More recently, a novel function of SDHA has been identified in a human breast cancer cell line deficie…”
InfluentialSuccinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics
Her, Y. F., & Maher, L. J. (2015) · International Journal of Endocrinology · doi:10.1155/2015/296167 · Cited by 58
Castro, B. D., Pintado, C. O., García‐Flores, P., López‐Barneo, J., & Piruat, J. I. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00128-12 · Cited by 55
“mouse is expected to increase the production of ROS in mitochondria, as 322 mutations in Sdh proteins have been demonstrated to increase oxidative stress in 323 both in vivo and in vitro systems (19, 25).”
BackgroundInfluentialCastelblanco, E., Santacana, M., Valls, J., Cubas, A. D., Cascón, A., Robledo, M., & Matías‐Guiu, X. (2013) · Endocrine Pathology · doi:10.1007/s12022-013-9269-4 · Cited by 51
Merlo, A., Fernández, S. B. D. Q., Secades, P., Zambrano, I., Balbín, M., Astudillo, A., Scola, B., Arístegui, M., Suarez, C. M., & Chiara, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2410 · Cited by 55
Reynolds, M. B., Hong, H. S., Michmerhuizen, B. C., Lawrence, A.-L. E., Zhang, L., Knight, J. S., Lyssiotis, C. A., Abuaita, B. H., & O’Riordan, M. X. (2023) · Science Advances · doi:10.1126/sciadv.ade8701 · Cited by 54
Piantadosi, C. A., & Suliman, H. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709741200 · Cited by 51
Yang, C., Matro, J. C., Huntoon, K. M., Ye, D. Y., Huynh, T., Fliedner, S. M. J., Breza, J., Jr., Zhuang, Z., & Pacák, K. (2012) · The FASEB Journal · doi:10.1096/fj.12-210146 · Cited by 54
Xu, J., Pan, H., Xie, X., Zhang, J., Wang, Y., & Yang, G. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.09.041 · Cited by 50
Gu, C., Yang, H., Chang, K., Zhang, B., Xie, F., Ye, J., Chang, R., Qiu, X., Wang, Y., Qu, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.009 · Cited by 54
Sensitivity of hematopoietic stem cells to mitochondrial dysfunction by SdhD gene deletion
Bejarano-García, J. A., Millán‐Uclés, Á., Rosado, I. V., Sánchez‐Abarca, L. I., Caballero‐Velázquez, T., Durán-Galván, M. J., Pérez‐Simón, J. A., & Piruat, J. I. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.411 · Cited by 56
“In this regard, we 33 and others 45,46 have demonstrated oxidative stress in MCII-deficient cells, which could contribute to the loss of cell viability observed in the SDHD-ESR BM.”
Fuchs, A. L., Schiller, S. M., Keegan, W. J., Ammons, M. C. B., Eilers, B. J., Tripet, B., & Copié, V. (2019) · Metabolites · doi:10.3390/metabo9110248 · Cited by 56
“This suggests that our M1 MΦs may experience some level of succinate dehydrogenase (SDH) inhibition, as previously determined by others [5,40,49], since M1 MΦs exhibit a higher intracellular succinate to fumarate ratio than either M0 or M2a MΦs.”
From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma
Lussey‐Lepoutre, C., Thibault, C., Buffet, A., Morin, A., Badoual, C., Bénit, P., Rustin, P., Ottolenghi, C., Janin, M., Castro‐Vega, L. J., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.027 · Cited by 58
“Finally, a xenograft model using shRNA mediated SDHB knocked-down in 143B human osteosarcoma cells was generated by Guzy and colleagues (Guzy et al., 2008).”
Dynamic regulation of epigenetic demethylation by oxygen availability and cellular redox
Lamadema, N., Burr, S., & Brewer, A. C. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.009 · Cited by 54
“Evidence for the involvement of both mitochondrial- and NADPH oxidase-derived ROS have been reported [125-130], but complete validation of the importance of either (or both) will probably await”
BackgroundPheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
Pang, Y. K., Liu, Y., Pacák, K., & Yang, C. (2019) · Cancers · doi:10.3390/cancers11040436 · Cited by 52
“Studies using in vivo and in vitro models have shown that loss of succinate dehydrogenase activity results in: (i) abnormal activation of hypoxia-signaling pathway in the presence of oxygen (pseudohypoxia) and angiogenesis [26]; (ii) increased production of reactive oxygen species (ROS) [27]; and (iii) impeded repair…”
BackgroundMitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology
Fujiwara, H., Seike, K., Brooks, M. D., Mathew, A. V., Kovalenko, I., Pal, A., Lee, H., Peltier, D., Kim, S. H., Liu, C., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01048-3 · Cited by 47
Cardaci, S., Rizza, S., Filomeni, G., Bernardini, R., Bertocchi, F., Mattei, M., Paci, M., Rotilio, G., & Ciriolo, M. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1741 · Cited by 45
“B), the subunit responsible for succinate oxidation and electrons entering into the redox core of complex II (24, 25).”
A review of the mechanism of succinylation in cancer
Lu, K., & Han, D. (2022) · Medicine · doi:10.1097/md.0000000000031493 · Cited by 46
“Succinylation sites in the nucleus were mainly concentrated in the promoter region, suggesting that succinylation may be involved in the transcriptional regulation of genes.[20] As the only respiratory enzyme involved in both the tricarboxylic acid cycle and electron transport chain, Mitochondrial complex II (CII), al…”
BackgroundSuccinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme
Esteban-Amo, M. J., Jiménez-Cuadrado, P., Serrano‐Lorenzo, P., de la Fuente, M. Á., & Simarro, M. (2024) · Biomedicines · doi:10.3390/biomedicines12092050 · Cited by 60
Mitochondrial complex II and genomic imprinting in inheritance of paraganglioma tumors
Baysal, B. E. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.12.005 · Cited by 46
Liu, Y., Pang, Y. K., Zhu, B., Uher, O., Caisová, V., Huynh, T., Taïeb, D., Vanova, K. H., Ghayee, H. K., Neužil, J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2335 · Cited by 50
“Furthermore, compromised mitochondrial complex II disrupts electron transfer to oxygen, leading to increased formation of reactive oxygen species (ROS) and redox imbalance (11, 12).”
Background
Metadata
- Authors
- Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T.
- Affiliations
- Department of Pediatrics, Division of Neonatology
- Northwestern University (US)
- Corresponding author
- Schumacker, Paul T.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-01-01
- Volume
- 28
- Issue
- 2
- Pages
- 718-731
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2223429
- OpenAlex
- W2149282639
- Semantic Scholar
- b18b26c88fdc8fd4b5c2258a52b72d9bb98605aa
- Cited by
- 427
- References
- 54
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 20 · 2023: 29 · 2022: 18 · 2021: 30 · 2020: 31 · 2019: 22 · 2018: 26 · 2017: 18 · 2016: 23 · 2015: 24 · 2014: 32 · 2013: 22 · 2012: 29
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 32646, HL079650, R01HL035440, R01HL079650, HL35440)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- succinate dehydrogenase, SDHB, SDHA, reactive oxygen species, hypoxia-inducible factor alpha, HIF-1α, HIF-2α, tumor suppressor, carcinogenesis, cell proliferation
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Humans, Iron-Sulfur Proteins, Male, Mice, Nude, Neoplasm Transplantation, Protein Binding, Succinate Dehydrogenase, Signal Transduction, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Protein Subunits, RNA Interference, Electron Transport Complex II, Cell Line, Tumor, Cell Proliferation, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.